X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare with JUBILANT LIFE SCIENCES - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALKEM LABORATORIES vs JUBILANT LIFE SCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALKEM LABORATORIES JUBILANT LIFE SCIENCES ALKEM LABORATORIES/
JUBILANT LIFE SCIENCES
 
P/E (TTM) x - 19.8 - View Chart
P/BV x 6.5 4.8 136.8% View Chart
Dividend Yield % 0.7 0.4 174.2%  

Financials

 ALKEM LABORATORIES   JUBILANT LIFE SCIENCES
EQUITY SHARE DATA
    ALKEM LABORATORIES
Mar-16
JUBILANT LIFE SCIENCES
Mar-14
ALKEM LABORATORIES/
JUBILANT LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs1,589187 850.6%   
Low Rs1,23265 1,892.5%   
Sales per share (Unadj.) Rs417.5364.3 114.6%  
Earnings per share (Unadj.) Rs56.36.8 822.3%  
Cash flow per share (Unadj.) Rs64.724.5 264.1%  
Dividends per share (Unadj.) Rs12.703.00 423.3%  
Dividend yield (eoy) %0.92.4 37.8%  
Book value per share (Unadj.) Rs292.9164.9 177.6%  
Shares outstanding (eoy) m119.57159.28 75.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.40.3 977.4%   
Avg P/E ratio x25.118.4 136.2%  
P/CF ratio (eoy) x21.85.1 424.0%  
Price / Book Value ratio x4.80.8 630.4%  
Dividend payout %22.643.8 51.5%   
Avg Mkt Cap Rs m168,65320,061 840.7%   
No. of employees `000NA6.2 0.0%   
Total wages/salary Rs m9,17111,052 83.0%   
Avg. sales/employee Rs ThNM9,383.0-  
Avg. wages/employee Rs ThNM1,786.9-  
Avg. net profit/employee Rs ThNM176.3-  
INCOME DATA
Net Sales Rs m49,91558,034 86.0%  
Other income Rs m1,645191 863.1%   
Total revenues Rs m51,56158,224 88.6%   
Gross profit Rs m8,4825,786 146.6%  
Depreciation Rs m1,0062,812 35.8%   
Interest Rs m6713,237 20.7%   
Profit before tax Rs m8,451-72 -11,721.2%   
Minority Interest Rs m-114-286 39.8%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m02,145 0.0%   
Tax Rs m1,606696 230.6%   
Profit after tax Rs m6,7311,090 617.3%  
Gross profit margin %17.010.0 170.4%  
Effective tax rate %19.0-965.9 -2.0%   
Net profit margin %13.51.9 717.7%  
BALANCE SHEET DATA
Current assets Rs m27,06229,280 92.4%   
Current liabilities Rs m15,32438,912 39.4%   
Net working cap to sales %23.5-16.6 -141.7%  
Current ratio x1.80.8 234.7%  
Inventory Days Days6784 78.8%  
Debtors Days Days4151 81.4%  
Net fixed assets Rs m12,61055,712 22.6%   
Share capital Rs m239155 154.8%   
"Free" reserves Rs m34,49020,968 164.5%   
Net worth Rs m35,02726,265 133.4%   
Long term debt Rs m1,21217,169 7.1%   
Total assets Rs m54,38788,606 61.4%  
Interest coverage x13.61.0 1,391.2%   
Debt to equity ratio x00.7 5.3%  
Sales to assets ratio x0.90.7 140.1%   
Return on assets %13.64.9 278.6%  
Return on equity %19.24.2 462.9%  
Return on capital %24.911.6 214.9%  
Exports to sales %12.937.8 34.2%   
Imports to sales %3.116.5 18.7%   
Exports (fob) Rs m6,46121,933 29.5%   
Imports (cif) Rs m1,5409,567 16.1%   
Fx inflow Rs m6,56322,004 29.8%   
Fx outflow Rs m3,01211,749 25.6%   
Net fx Rs m3,55210,255 34.6%   
CASH FLOW
From Operations Rs m7,2598,026 90.4%  
From Investments Rs m1,864-1,744 -106.9%  
From Financial Activity Rs m-9,273-4,447 208.5%  
Net Cashflow Rs m-1501,834 -8.2%  

Share Holding

Indian Promoters % 66.9 45.6 146.7%  
Foreign collaborators % 0.0 3.5 -  
Indian inst/Mut Fund % 33.1 8.7 380.5%  
FIIs % 0.0 21.2 -  
ADR/GDR % 0.0 0.0 -  
Free float % 0.0 21.1 -  
Shareholders   68,381 23,815 287.1%  
Pledged promoter(s) holding % 0.0 15.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALKEM LABORATORIES With:   ALEMBIC PHARMA  FRESENIUS KABI ONCO.  GLENMARK PHARMA  ABBOTT INDIA  STRIDES SHASUN LTD  

Compare ALKEM LABORATORIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Tata Steel & Dr. Reddy's Top Losers(09:30 am)

Asian share markets are lower today as Japanese and Hong Kong shares fall. The Nikkei 225 is off 1.3% while the Hang Seng is down 1%. The Shanghai Composite is trading down by 0.8%.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

Beware of Inflated Stock Market Angels(Sector Info)

May 17, 2018

The stock of Vakrangee helps us understand why it's a bad idea to chase high-flying stocks.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ALKEM LABORATORIES SHARE PRICE


May 23, 2018 12:31 PM

TRACK ALKEM LABORATORIES

  • Track your investment in ALKEM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALKEM LABORATORIES

ALKEM LABORATORIES - MERCK LTD COMPARISON

COMPARE ALKEM LABORATORIES WITH

MARKET STATS